C0006230||Bromocriptine
C0004391||Autophagy
C0007587||Cell Death
C0032000||Pituitary Adenomas
C0006230||Bromocriptine
C0006230||Bromocriptine
C0033375||prolactinoma
C0006230||Bromocriptine
C0030664||pathology
C1519524||paraffin-embedded prolactinoma tissue
C2003747||LC3
C0442726||detected
C0021044||immunohistochemistry
C0229535||GH3
C0229535||MMQ cells
C0006230||Bromocriptine
C0072980||rapamycin
C0072980||rapamycin
C0007620||Cell viability
C0007586||cell cycle
C2986858||CCK-8
C0016263||flow cytometry
C0014441||Enzyme-linked immunosorbent assay
C2611224||prolactin secretion
C1171362||Protein expression
C0442726||detected
C0005863||Western blot
C0079603||immunofluorescence
C2003747||LC3
C1171362||expressed
C0033375||prolactinoma
C0006230||Bromocriptine
C1171362||LC3 expression
C0205160||negative
C0040300||tissues
C0033375||prolactinoma
C0332293||treated with
C0006230||Bromocriptine
C0087111||Treatment
C0006230||Bromocriptine
C0007587||cell death
C0229535||MMQ cells
C0006230||Bromocriptine
C0229535||GH3 cells
C0007586||cell cycle
C1155873||arrested
C0079394||G0
C1155840||G1 phase
C1155869||S phase
C2003747||LC3-I
C2003747||LC3-II
C2611224||prolactin secretion
C0293686||Bcl-2
C0219474||BAX
C1171362||expression
C0007620||cell viability
C0428411||prolactin level
C0229535||MMQ cells
C0332293||treated with
C0072980||rapamycin
C0006230||Bromocriptine
C0229535||MMQ cells
C0332293||treated with
C0006230||Bromocriptine
C0006230||Bromocriptine
C0087111||treatment
C0072980||rapamycin
C0006230||Bromocriptine
C2003747||LC3-I
C2003747||LC3-II
C0006230||Bromocriptine
C0032000||pituitary adenoma
C0334227||cells
C0004391||autophagic
C0007587||cell death
C0162638||apoptosis